03.23.26 -- 5 QMS Blind Spots You Should Know About

By integrating perfusion into upstream manufacturing, see how this approach has achieved up to a fivefold increase in productivity, delivering titers that significantly exceed current industry benchmarks.

A high-performance, helper virus-free stable producer cell line is derived from proprietary high-producer HEK293 cells and is cultivated in a chemically defined, serum-free, ADCF medium in suspension.

While clinical efficacy is the critical benchmark for any drug program, ensuring manufacturability is also vital. An experienced CDMO can help you establish efficient and cost-effective production strategies.

Switch to animal-free alternatives for E. coli growth. Plant-based peptones support higher plasmid yields and controlled induction, offering a sustainable solution for biopharmaceutical culture.

Modernize your outsourcing by using AI to evaluate partner bids. Compare traditional selection methods with automated tools designed to reduce costs and accelerate the procurement timeline.

Choosing the right bioanalysis CRO is vital to avoid costly delays. Sponsors need evaluation strategies that prioritize proven quality, predictable timelines, and submission-ready data.

Gain insights into how standardized quality controls, robust analytics, and streamlined processes can improve efficiency, reliability, and scalability across the development lifecycle.

Examine how a partnership leveraging expertise in production for high-quality CRISPR gRNAs as well as cGMP manufacturing is supporting the clinical translation of CRISPR genome editing technologies.

Discover how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics. Learn to balance performance, cost, and supply to make smart choices for your xRNA manufacturing.

Achieve efficient, cGMP-ready production for AAV, Lentiviral, and Adenoviral vectors. This robust clonal solution supports diverse serotypes and CAR-T applications for global manufacturing.